Rosetta Genomics Ltd. (ROSG) Hits New 12-Month Low at $0.90
Rosetta Genomics Ltd. (NASDAQ:ROSG)’s share price hit a new 52-week low during trading on Tuesday . The company traded as low as $0.90 and last traded at $0.92, with a volume of 676,111 shares traded. The stock had previously closed at $1.00.
The company has a 50-day moving average price of $1.33 and a 200 day moving average price of $1.94. The company’s market cap is $2.41 million.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/rosetta-genomics-ltd-rosg-hits-new-12-month-low-at-0-90/1637036.html.
About Rosetta Genomics
Rosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence In Situ Hybridization (FISH).
Receive News & Ratings for Rosetta Genomics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rosetta Genomics Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.